Search & Evaluation: Exploring the world for innovative compound

The dedicated Search & Evaluation team engages with companies across the globe, exploring potential opportunities for in-licensing. Our experts possess a keen eye for identifying groundbreaking projects that align with Debiopharm’s strategic vision, ensuring that we continue to make a significant impact on the healthcare landscape.

How is Search & Evaluation pivotal in driving our mission to develop innovative therapies for patients?

Our qualified scientists evaluate the data package generated on each pharmaceutical drug candidate or program. They lead the due diligence process to prepare an adequate development plan for the program and ensure a maximal potential benefit to patients.

Search & Evaluation Business Model Debiopharm

What we are looking for

We are constantly looking for innovative assets. Should your program meet the following criteria, we’re your partner of choice.

Universities, Biotech, Big pharma
Therapeutic Areas
Oncology, Bacterial Infections
Development Stages
From preclinical to early clinical phase I
Drug classes
Small molecules and biologics

Frédéric Lévy Chief Scientific Officer, Search & Evaluation and Scientific Innovation

Don't hesitate to get in touch if you have an interesting project

Get in touch